1. Targeting Inflammation, PHA-767491 Shows a Broad Spectrum in Protein Aggregation Diseases
   Yu-Han Chung et al, 2020, Journal of Molecular Neuroscience CrossRef
2. Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells
   Shushi Huang et al, 2021, Aging CrossRef
3. CDK9 binds and activates SGK3 to promote cardiac repair after injury via the GSK-3β/β-catenin pathway
   Jiateng Sun et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
4. P-TEFb as A Promising Therapeutic Target
   Koh Fujinaga, 2020, Molecules CrossRef
5. miR‐206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9
   Chi Pang et al, 2017, Cancer Medicine CrossRef
6. Down-regulating cyclin-dependent kinase 9 of alloreactive CD4+ T cells prolongs allograft survival
   Yang Zhan et al, 2016, Oncotarget CrossRef
7. Ensemble-based modeling and rigidity decomposition of allosteric interaction networks and communication pathways in cyclin-dependent kinases: Differentiating kinase clients of the Hsp90-Cdc37 chaperone
   Gabrielle Stetz et al, 2017, PLOS ONE CrossRef
8. RNA-Seq of Liver From Pigs Divergent in Feed Efficiency Highlights Shifts in Macronutrient Metabolism, Hepatic Growth and Immune Response
   Justyna Horodyska et al, 2019, Frontiers in Genetics CrossRef
9. Long Non-coding RNA PEBP1P2 Suppresses Proliferative VSMCs Phenotypic Switching and Proliferation in Atherosclerosis
   Xingqiang He et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
10. Serum cyclin-dependent kinase 9 is a potential biomarker of atherosclerotic inflammation
    Yeming Han et al, 2016, Oncotarget CrossRef
11. The Pharmacological Implications of Flavopiridol: An Updated Overview
    Hemant Joshi et al, 2023, Molecules CrossRef
12. Transcriptional cyclin-dependent kinases as the mediators of inflammation-a review
    Vaishnavi Sundar et al, 2021, Gene CrossRef